228 Results
New Opportunity to Explore Sex Differences in Radiation Research
Funding News Edition: June 7, 2023
Have you observed radiation-associated sex differences in your early-stage research to advance animal models, medical countermeasure development, safety, or biomarker science?
Analyze Mechanistic Studies of Early Events in TB/HIV Infection
Funding News Edition: June 7, 2023
Conduct mechanistic studies of early-stage Mtb infection in the airway and lungs with and without HIV to identify interventional targets for vaccine and host-directed therapies.
Opportunity to Create a Bioinformatics Research Center
Funding News Edition: June 7, 2023
Each center will create and provide access to interactive knowlegebases, innovative tools and software, and leading-edge expertise in bioinformatics.
Examine Public Feedback on Plan for Simplifying Review Criteria
Funding News Edition: June 7, 2023
NIH received more than 800 responses to a request for information on simplifying peer review criteria, a vast majority of which supported most of the proposed changes.
Check Out Resources on Sex as a Biological Variable
Funding News Edition: June 7, 2023
NIH’s Office of Research on Women’s Health offers training modules, videos, and other tools to instruct biomedical researchers on properly accounting for sex as a biological variable.
Liquidation—Money Matters for When Your Time Is Up
Funding News Edition: June 7, 2023
NIH grant recipients have 120 days from the end of a performance period to liquidate obligations by drawing funds from the Payment Management System.
“What is the difference between the AREA and REAP research enhancement awards?”
Funding News Edition: June 7, 2023
Provide Feedback to Improve Fellowship Application Review Criteria
Funding News Edition: June 7, 2023
NIH tasks peer reviewers with identifying the most promising trainees as well as excellent, individualized training programs that will help them become outstanding scientists.
Quiz Yourself on NIH Grant Funding Terminology
Funding News Edition: May 17, 2023
How familiar are you with NIAID’s application and grant terminology? Test your knowledge by taking our quiz and pay attention to the explanations for each answer.

Initiative Takes International Approach to Infectious Diseases
Funding News Edition: May 17, 2023
Apply if you are an international investigator in a resource-constrained country and can propose high-priority, regionally relevant infectious diseases research.
Apply for Funds to Develop Innovative, High-Impact HIV Vaccine Approaches
Funding News Edition: May 17, 2023
The initiative supports early discovery of novel exploratory vaccine strategies to prevent HIV infection, as well as worthy basic vaccine discovery research that has not yet been fully exploited.
Research Synthetic Nucleic Acid Platforms to Fight HIV
Funding News Edition: May 17, 2023
Propose research to apply newly developed immunological tools and expand understanding of the immune response to vaccination at the molecular level.
Lasker Program—Join NIH as a Clinical Researcher
Funding News Edition: May 17, 2023
NIH will employ and support up to five exceptional early-stage investigators who have not yet achieved tenure at a research institution.
Provide Input on NIH Herpes Simplex Virus Strategic Plan
Funding News Edition: May 17, 2023
Share feedback on NIH's Herpes Simplex Virus Strategic Plan and its prioirities for basic research, diagnosis, treatment, cure, and prevention by June 21, 2023.
NIAID Posts Final FY 2023 Paylines for R01, R15 Grants
Funding News Edition: May 17, 2023
NIAID sets a separate R01 payline for new and early-stage principal investigators (PIs) to ensure success rate parity between established and new and early-stage PIs.
Reference NIH Data on Cumulative Investigator Rates
Funding News Edition: May 17, 2023
The Cumulative Investigator Rate is calculated as the number of unique principal investigators (PIs) who were designated on an NIH research project grant divided by the number of unique PIs who were designated on applications over a 5-year period.
Caution—Roles Determine Eligibility and Other Requirements
Funding News Edition: May 17, 2023
We cover role-related terms that have caused confusion like co-investigator, collaborator, consultant, other significant contributor, and staff scientist.
“My withdrawn resubmission application is still listed in the eRA Commons. Can I submit an updated version of the same application?”
Funding News Edition: May 17, 2023
“Does NIAID set a limit for how much total funding support an investigator can receive across all grant awards?”
Funding News Edition: May 17, 2023
There’s More to Biosafety and Biosecurity Than Select Agents
Funding News Edition: May 3, 2023
Review key terminology like dual use research of concern, enhanced potential pandemic pathogens, select agents, and recombinant or synthetic nucleic acid molecules.

Propose Research on Mechanisms of Viral Invasion of Central Nervous System
Funding News Edition: May 3, 2023
Apply if you can conduct research focused on less-studied emerging and re-emerging neurotropic viruses for which there are currently no approved vaccines or therapeutics.
Reissued Funding Opportunity Centers on ME/CFS
Funding News Edition: May 3, 2023
Collaborative research centers will help provide the foundation and infrastructure to complete basic, translational, and mechanistic clinical trials focused on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Resources for Sites Providing Diagnostic Services for Patients with Undiagnosed Diseases
Funding News Edition: May 3, 2023
Demonstrate that your clinical site has a track record of diagnosing rare and difficult-to-diagnose disorders, with appropriate expertise as well as the infrastructure and resources needed to conduct clinical evaluation and DNA sequencing of participants enrolled at your site.
Extended Deadline for Characterization of HIV Vaccine Formulations BAA
Funding News Edition: May 3, 2023
NIAID has extended the application deadline for the broad agency announcement (BAA) Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine Candidates; proposals are now due on July 7, 2023, at 4 p.m. Eastern Time.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.